CRA Diamond Member News: Pfizer Study Recruitment

Pfizer’s Myositis Research

Do you have patients with Dermatomyositis or Polymyositis who may be eligible to participate in an ongoing Phase 3 clinical research study? 

• This study is currently recruiting in 9 states in the USA and will add additional sites in the USA and internationally.

• Additional details about the study (NCT05895786; Protocol number C0251006) can be found at  .

Sponsored by Pfizer Inc